Related Experiment Video
Updated: May 23, 2026

Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model
Published on: June 20, 2025
Clinical Significance and Mechanistic Role of circLPAR3/miR-634 in Ischemic Stroke
Jinli Chen1, Jing Yang2, Quan Wu1
1Department of Neurology, Tinglin Hospital of Jinshan District, Shanghai, 201505, China.
Insights
Circular RNA LPAR3 (circLPAR3) levels are decreased in patients with ischemic stroke (IS). Upregulating circLPAR3 protects against IS by reducing neuronal apoptosis and inflammation, offering a potential therapeutic target for stroke patients.
Area of Science:
- Biochemistry
- Molecular Biology
- Neuroscience
Background:
- Hypertension is a significant risk factor for ischemic stroke (IS), a leading cause of human disability and mortality.
- Understanding the molecular mechanisms underlying IS is crucial for developing effective therapeutic strategies.
Purpose of the Study:
- To investigate the role of circular RNA LPAR3 (circLPAR3) in the pathogenesis of IS.
- To elucidate the functional effects and molecular mechanisms of circLPAR3 in IS.
Main Methods:
- Quantification of mRNA abundance using RT-qPCR in patients and cell/animal models.
- In vivo studies using mice subjected to middle cerebral artery occlusion (MACO) and in vitro studies using oxygen-glucose deprivation/reoxygenation (OGD/R) in Neuro-2a cells.
- Luciferase reporter and RNA immunoprecipitation (RIP) assays to determine molecular interactions.
Main Results:
- Plasma circLPAR3 levels were significantly reduced in IS patients compared to essential hypertension (EH) patients and served as an independent predictor of poor prognosis.
- Overexpression of circLPAR3 in vivo ameliorated neurological deficits and infarct volume in MACO-treated mice.
- circLPAR3 upregulation attenuated OGD/R-induced neuronal apoptosis and pro-inflammatory cytokine release in vitro.
- circLPAR3 acts as a molecular sponge for miR-634, and KLB is a downstream target mediating circLPAR3's neuroprotective effects.
Conclusions:
- circLPAR3 plays a protective role in IS by inhibiting neuronal apoptosis and inflammation.
- The circLPAR3/miR-634/KLB axis represents a potential therapeutic target for managing IS.
Abstract:
Individuals with hypertension carry a high risk of stroke, which endangers human health. The study systematically elucidated the dynamic expression, functional effects, and molecular mechanisms of the circular RNA LPAR3 in ischemic stroke (IS). 300 essential-hypertension (EH) patients were enrolled, comprising 165 cases diagnosed with IS. mRNA abundance was quantified via RT-qPCR. C57BL/6 mice treated with MACO and Neuro-2a cells receiving oxygen-glucose deprivation/reoxygenation (OGD/R) were applied for functional experiments. Neurological deficits and infarct volume of mice were evaluated. Besides, key cellular behaviors encompassing proliferative capacity, apoptotic rate, and inflammatory response were monitored. The putative binding event was interrogated through luciferase reporter and RIP coupled to qPCR assays. A diminished level of circLPAR3 was evidenced in the plasma of IS patients, which can distinguish IS cases from EH and remains an independent predictor of patients' poor prognosis. In vivo, overexpression of circLPAR3 alleviated MACO-mediated neurological deficit and cerebral infarction. In vitro, OGD/R triggered the surge in cell apoptosis and pro-inflammatory cytokine release, but it was attenuated by circLPAR3 upregulation. Mechanistically, the neuro-rescue driven by circLPAR3 was offset by miR-634, whose plasma expression was negatively correlated with circLPAR3. KLB expression was significantly downregulated in cellular models and co-regulated by circLPAR3 and miR-634. circLPAR3/miR-634 modulates the pathological progression of IS by directly regulating neuronal apoptosis and orchestrating inflammatory responses, and KLB may serve as a key downstream target mediating the biological functions.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology